Isoniazid/pyrazinamide/rifampicinHepatitis: 5 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1818卷 / 1期

关键词：

D O I：

10.1007/s40278-020-82438-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：158 / 158

相关论文

共 50 条

[31] Isoniazid/pyrazinamide/rifampicinLiver injury: case report
Reactions Weekly, 2023, 1983 (1) : 250 - 250
[32] Isoniazid/pyrazinamide/rifampicinDRESS syndrome: case report
Reactions Weekly, 2017, 1656 (1) : 283 - 283
[33] Isoniazid/leflunomide/tocilizumabVarious toxicities: 5 case reports
Reactions Weekly, 2019, 1744 (1) : 170 - 170
[34] Moxifloxacin/rifampicinHepatitis and acquired resistance to rifampicin: 2 case reports
Reactions Weekly, 2018, 1683 (1) : 474 - 474
[35] Rifampicin/isoniazid/pyrazinamide/ethambutolLack of efficacy: case report
Reactions Weekly, 2023, 1965 (1) : 423 - 423
[36] Isoniazid/Pyrazinamide/Rifampicin Interaction: Hepatitis: Case Report
不详
MOLECULAR DIAGNOSIS & THERAPY, 2010, 14 (03) : 197 - 198
[37] Ethambutol/isoniazid/pyrazinamide/rifampicinHypersensitivity reaction: case report
Reactions Weekly, 2015, 1578 (1) : 140 - 140
[38] Rifampicin/isoniazid/pyrazinamide/ethambutolBinocular blindness: case report
Reactions Weekly, 2020, 1794 (1) : 204 - 204
[39] Rifampicin/isoniazid/pyrazinamide/ethambutolLiver injury: case report
Reactions Weekly, 2025, 2049 (1) : 319 - 319
[40] Rifampicin/isoniazid/pyrazinamide/ethambutolLiver toxicity: case report
Reactions Weekly, 2012, 1397 (1) : 28 - 28

← 1 2 3 4 5 →